Literature DB >> 2091134

[The inefficacy of zidovudine (AZT) in progressive multifocal leukoencephalopathy (PML) associated with the acquired immunodeficiency syndrome (AIDS)].

F J Garrote1, J A Molina, C Lacambra, M Mollejo, S Madero, T del Ser.   

Abstract

The clinical case of a patient suffering AIDS who presented a progressive multifocal leukoencephalopathy (PML), diagnosed by CT scan, magnetic resonance imaging (MRI) and cerebral biopsy, is here described. A therapeutic trial was carried out with zidovudine (200 mg/4 hours p.o.) during 75 days. Although this treatment diminished the number of infections, a progression of PML was clinically observed, as well as the appearance of new lesions in the cerebral white matter in the MRI. The inefficacy of zidovudine in PML associated to AIDS is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091134

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  2 in total

1.  Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.

Authors:  T Baldeweg; J Catalan; B G Gazzard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

2.  From Clinical Presentation to the Outcome: the Natural History of PML in a Portuguese Population of HIV Infected Patients.

Authors:  Filipe Nery; Margarida Franca; Isabel Almeida; Carlos Vasconcelos
Journal:  J Clin Med Res       Date:  2011-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.